聯(lián)系我們時請說明是91化工儀器網(wǎng)上看到的信息,謝謝!
AASS抗體
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500not yet tested in other applications.
optimal dilutions/concentrations should be determ 【詳細(xì)說明】
英文名稱 AASS
中文名稱 賴氨酸酮戊二酸還原酶抗體
別 名 Alpha aminoadipic semialdehyde synthase mitochondrial; LKR/SDH; LKRSDH; LORSDH; Lysine ketoglutarate reductase; Saccharopine dehydrogenase; AASS_HUMAN.
AASS抗體
說 明 書 0.2ml
研究領(lǐng)域 腫瘤 細(xì)胞生物 信號轉(zhuǎn)導(dǎo)
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep,
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 99kDa
性 狀 Lyophilized or Liquid
濃 度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human LKRSDH (878-926aa)
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
AASS抗體
PubMed PubMed
產(chǎn)品介紹 background:
Alpha-aminoadipic semialdehyde synthase (AASS), also designated lysine ketoglutarate reductase (LKR) or saccharopine dehydrogenase (SDH), is a 926 amino acid protein that exists as a homodimer in the mitochondria. AASS acts as a bifunctional enzyme containing the lysine alpha-ketoglutarate reductase (LKR) and saccharopine dehydrogenase activities that catalyzes the first two steps in lysine degradation. It is widely expressed with highest expression in liver and transcription of the AASS gene is induced upon starvation. Mutations in the gene encoding AASS result in various forms familial hyperlysinemias (FH), autosomal recessive disorders characterized by hyperlysinemia, lysinuria, and variable saccharopinuria. However, no adverse mental or physical effects have been found in patients with hyperlysinemia.
Function:
Bifunctional enzyme that catalyzes the first two steps in lysine degradation. The N-terminal and the C-terminal contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively.
Subunit:
Homodimer
Subcellular Location:
Mitochondrial
Tissue Specificity:
Expressed in all 16 tissues examined with highest expression in the liver.
DISEASE:
Defects in AASS are the cause of hyperlysinemia (HYPLYS) [MIM:238700]. Hyperlysinemia is an autosomal recessive condition characterized by hyperlysinemia lysinuria and variable saccharopinuria.
Similarity:
In the N-terminal section; belongs to the AlaDH/PNT family.
In the C-terminal section; belongs to the saccharopine dehydrogenase family.
Database links:
Entrez Gene: 10157 Human
Omim: 605113 Human
SwissProt: Q9UDR5 Human
Unigene: 156738 Human
important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
相關(guān)產(chǎn)品:yb-3150R Phospho-FLT3 (Tyr842)磷酸化FMS樣酪氨酸激酶3 技術(shù)參考
yb-3151R Phospho-FLT3 (Tyr969)磷酸化FMS樣酪氨酸激酶3 技術(shù)參考
yb-3152R Phospho-c-Fos (Ser32)磷酸化c-fos抗體 技術(shù)參考
yb-3153R Phospho-c-Fos(Thr232)磷酸化c-fos抗體 技術(shù)參考
yb-3154R Phospho-c-Fos (Thr325)磷酸化c-fos抗體 技術(shù)參考
yb-4201R FIH1缺氧誘導(dǎo)因子1α抑制蛋白抗體 技術(shù)參考
yb-0949R F1 operon positive regulatory protein(NT)肺鼠疫耶爾森氏菌F1莢膜蛋白抗體(N端) 技術(shù)參考
yb-1745R Factor H補(bǔ)體因子H抗體 技術(shù)參考
yb-1536R FSH beta促卵泡刺激素抗體 技術(shù)參考
yb-1613R FOX3神經(jīng)元核抗原抗體 技術(shù)參考
yb-9063R FAM135BFAM135B蛋白抗體 技術(shù)參考
yb-0809R Fibulin 1“衰老關(guān)鍵蛋白"抗體 技術(shù)參考
yb-0895R FSH receptor促卵泡刺激素受體抗體 技術(shù)參考
yb-9760R FGF12成纖維細(xì)胞生長因子12抗體 技術(shù)參考
yb-9761R FGF14成纖維細(xì)胞生長因子14抗體 技術(shù)參考
yb-2135R FABPB腦型脂肪酸結(jié)合蛋白抗體 技術(shù)參考
yb-9729R FAM96BFAM96B蛋白抗體 技術(shù)參考
yb-9721R FEZ1腦胚胎鋅指樣蛋白1抗體 技術(shù)參考
yb-9723R FAM29AFAM29蛋白抗體 技術(shù)參考
yb-9738R FASP1MaFF相關(guān)蛋白抗體 技術(shù)參考
yb-4846R Factor VII凝血因子7抗體 技術(shù)參考
yb-7113R FEM 1BFEM1B抗體 技術(shù)參考
yb-1255R FGF3纖維母細(xì)胞生長因子3抗體 技術(shù)參考
yb-1256R FGF4纖維母細(xì)胞生長因子4抗體 技術(shù)參考
yb-1154R FRA1FRA-1蛋白抗體 技術(shù)參考
yb-12264R FTSJ1精神發(fā)育遲滯相關(guān)蛋白抗體 技術(shù)參考
yb-12165R FAM62C延伸突觸蛋白3抗體 技術(shù)參考
yb-12166R Fibrillin 2原纖維蛋白2抗體 技術(shù)參考
yb-7662R FLI1尤文肉瘤FLI1蛋白抗體 技術(shù)參考
yb-7636R FUT1巖藻糖轉(zhuǎn)移酶1抗體 技術(shù)參考
yb-6766R FLIP delta + gamma凋亡調(diào)節(jié)蛋白δ+γ抗體 技術(shù)參考
yb-7068R FOXO1 + FOXO3 + FOXO4叉頭蛋白O1/O3/O4抗體 技術(shù)參考
yb-9730R FAM82B微管相關(guān)蛋白FAM82B抗體 技術(shù)參考
yb-7548R Fibrinogen alpha chain纖維蛋白原A鏈抗體 技術(shù)參考
yb-7061R FAIM1FAS凋亡抑制分子1抗體 技術(shù)參考
yb-6831R FAIM2FAS凋亡抑制分子2 技術(shù)參考
*驗(yàn)證碼: = 請輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7